Pharmacokinetics and efficacy of ectolysin P128 in a mouse model of systemic Methicillin Resistant Staphylococcus aureus (MRSA) infection.

Presented at ASM Microbe 2017, June 2017

Preclinical studies of anti-staphylococcal ectolysin P128 for potential systemic hypersensitivity and evaluation of efficacy in Staphylococcus aureus bacteremia with renal abscesses in rats.

Presented at ASM Microbe 2017, June 2017

Reversal of drug resistant phenotype of Staphylococcus clinical strains by synergistic action of P128 and antibiotics.

Presented at ASM Microbe 2017, June 2017

Bactericidal Activity of P128 on Coagulase Negative Staphylococci: Alone and in Combination with Antibiotics.

Presented at 27th ECCMID, April 2017

Killing of Persisters,Stationary Phase or Starved Cells of MRSA and CoNS by Anti-Staphylococcal Protein P128 .

Presented at 27th ECCMID, April 2017

In Vivo Synergy and Efficacy of P128 in Combination with Standard of Care Antibiotics in Methicillin Resistant Staphylococcus aureus (MRSA) Bacteremia

Presented at 27th ECCMID, April 2017

Eradication of Coagulase Negative Staphylococcus Biofilms by P128 Alone and Synergistic Inhibition in Combination with Antibiotics

Oral presentation. Presented at 27th ECCMID, April 2017

P128, a Novel Anti-Staphylococcal Protein to Treat S. aureus Infections in Wounds and in Bacteremia.

Presented at New Antibacterial Discovery & Development- Gordon Research conference, March 2016

Mechanism of Action of Anti-Staphylococcal Protein P128.

Presented at ICAAC, September 2013

Preclinical studies on P128, a novel anti-Staphylococcal protein.

Presented at the ASM 2010 Conference, May 2010

Preclinical Development of a novel antistaphylococcal Protein (P128) for Clearance of Nasal MRSA and for Prevention of MRSA colonization.

Presented at Gordon Research Conference on Staphylococcal Diseases, September 2009